Tweets
Taiwan claims data shows among 2050 new SLE, 783 on HCQ. HCQ had no effect on future development of CKD over 14 yrs. Yet some rec HCQ in all lupus nephritis to reduce kidney flares, ESKD and death. https://t.co/JS0ST1W0LW https://t.co/ihQp3d5rcy
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 3 months ago
Mark your calendars for our next Tuesday Night Rheumatology on 4/26 at 7pm!
Speakers will include:
Dr. Eric Ruderman
Dr. Arthur Kavanaugh
Dr. David Liew
Dr. Jack Cush
https://t.co/EqmilGRg5s
You can also find us LIVE on YouTube, Twitter, and Facebook. https://t.co/oW9zl1HudB
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 3 months ago
Download our newest set of slides on severe Psoriasis.
https://t.co/2j5Sp5IAgp https://t.co/QWUFcuu219
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 3 months ago
Open label, RCT compared triple DMARD Rx adding either LEF (MLH) or SSZ (MSH) to MTX+HCQ in 136 RA pts. Both were equally effective (non-inferior), 61.7% & 64.7% patients (p = 0.8) at wk 24. AE were also equal (15 vs 21 AE). https://t.co/fdPlMaTAyd
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 3 months ago
QD Clinic - PsA lessons and cases from the Rheumatology clinic.
Distinguishing Psoriatic arthritis from Erosive Osteoarthritis can be difficult
https://t.co/lrLdFszHR0 https://t.co/HaAZ820UfP
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 3 months ago
UK drug safety warning, observational data 2700 pregnancies, 1st trimester pregabalin (Lyrica) use was assoc w/ higher rate of congenital malformations (5.9 vs 4.1%). US PI label says Lyrica use in Pregnancy "May cause fetal harm". https://t.co/GdIitpe8KW
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 3 months ago
Beijing #RA Cohort study compared 102 T2T (CENTRA) vs 271 usual care pt (TARRA) groups for SDAI outcomes at 12 mos. CENTRA had signif lower SDAI than TARRA (2.1 vs 3.4; p<0.001) & more SDAI-defined remission (71% vs 49%; p<0.001) https://t.co/1JBP33eifI https://t.co/RmGny30QAq
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 3 months ago
QD Clinic - PsA Lessons from the Clinic
What are the Safe Treatment Options for psoriatics who have HIV?
QD Clinic is sponsored by RheumNow's PsA All the Way Campaign in April 2022
https://t.co/fh00ydSYd3 https://t.co/fpDl2tF4cw
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 3 months ago
Miss this blog from earlier in the month?
Dr. Eric Ruderman ( @jointMD) weighs in on combined clinics for PsA and its value.
https://t.co/4mdjmetGvF https://t.co/nJJXmk0a0t
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 3 months ago
ABP 654 is a Ustekinumab (anti-IL-12/23) biosimilar from Amgen - 563 pt, phase 3 trial shown to be equivalent to originator in mod- severe plaque psoriasis (no meaningful differences). ABP 654 is also being developed for Crohns & UC. https://t.co/vDNfMXCWcC
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 3 months ago
Italian retrospective of Canakinumab in 80 kids w/ Systemic JIA - 12 moved from anakinra to CAN w/ iinactive dz/CID. 58 pts w/ active SoJIA started CAN - CID in 57% at 6mos, 64% 12 mos; MAS 3/100PY; Nonresp assoc w/ MAS, #Jts, Dz duration https://t.co/2YmkukU7Z2
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 3 months ago
Open label, RCT compared triple DMARD Rx adding either LEF (MLH) or SSZ (MSH) to MTX+HCQ in 136 RA pts. Both were equally effective (non-inferior), 61.7% & 64.7% patients (p = 0.8) at wk 24. AE were also equal (15 vs 21 AE). https://t.co/cxdeBfo6XA
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 3 months ago
